Business ❯ Pharmaceutical Industry

Drug Manufacturing

Pricing Strategies Quality Control Investment Regulatory Compliance Market Competition Generic Drugs Investment Strategies Supply Chain Management Novo Nordisk Cost Management

Trump Seals Regeneron Drug-Pricing Pact, Completing 17-Company Push

The deal caps a White House push trading tariff relief for lower prices.

Delhi Court Pauses DRL’s ‘Olymviq’ Rollout in Ozempic Trademark Fight

Telangana Regulator Warns Against Unsupervised Semaglutide Use

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

UK Orders Recall of One Ramipril Batch After Amlodipine Found in Packs

Zentiva Recalls Ibuflam 600 mg Batch After Metal Fragment Found in Tablet

India Readies Dozens of Semaglutide Generics as Ozempic Patent Nears Expiry

Indian National Sentenced to 43 Months for Counterfeit Keytruda Scheme

TrumpRX.gov Launches With 40+ Lower-Priced Drugs as Companies Announce Cuts

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

Chicago Nurse Pleads Not Guilty to Federal Charges Over Counterfeit ‘Ozempic’ Injections

Delhi High Court Allows Zydus to Market Nivolumab Biosimilar on Public‑Interest Grounds

Argentina Names Luis Fontana to Lead ANMAT After Fentanyl Scandal

Trump Aide’s Son Criticized for Citing Brother’s Overdose to Defend U.S. Action on Venezuela

UK Sounds Alarm on Slimming Jabs After 60% Rise in Suspected Hospital Cases

Telangana Drug Regulator Logs 244 Seizures in 2025, First Arrests in Spurious-Drug Cases

Indian Immunologicals Challenges Australia’s Rabies Vaccine Alert as Reports Flag Communication Gaps

Anvisa Bans Sales and Advertising of Raia Drogasil’s Needs and Bwell Medicines

Investigation Finds Banned Insulin Still Dispensed in Peru Despite Recall Order